In this inaugural episode, experts discuss the limitations of current diagnosis-based frameworks in suicide research, emphasizing the need for more targeted interventions.
Jill M. Harkavy-Friedman, PhD
Advertisement
Dr Harkavy-Friedman is senior vice president of research at the American Foundation for Suicide Prevention.
Articles by Jill M. Harkavy-Friedman, PhD
In the first ever episode of "Psychopharm Today," experts unpack why suicide needs its own research, how to design targeted studies, and what clinicians can do beyond diagnosis to reduce risk.
The senior vice president of research at the American Foundation for Suicide Prevention offers thoughts on suicide and students.
Jill M. Harkavy-Friedman, PhD, Vice President of Research for the American Foundation for Suicide Prevention in New York City, briefs us on a pre-conference event.
Risk Factors for Suicide in Patients With Schizophrenia
Advertisement
Latest Updated Articles
- Risk Factors for Suicide in Patients With Schizophrenia
February 1st 2007
How to Help Clinicians Work With Suicidal PatientsOctober 2nd 2019
Advertisement
Advertisement
Trending on Psychiatric Times
1
Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD
2
Monoamines: A Full House
3
“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media
4
Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD
5